Masivet

Authorised

This medicine is authorised for use in the European Union

masitinib mesilate

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Masivet : EPAR - Summary for the public

Product information

Masivet : EPAR - Product Information

Masivet : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Masivet
• Active substance:
  Masitinib mesilate
• International non-proprietary name (INN) or common name:
  masitinib mesilate

Pharmacotherapeutic group

Antineoplastic agents

Authorisation details

• EMA product number:
  EMEA/V/C/000128

Assessment history

Changes since initial authorisation of medicine

Masivet : EPAR - Procedural steps taken and scientific information after authorisation

Masivet-V-C-128-II-06 : EPAR - Refusal Assessment Report - Variation

CVMP post-authorisation summary of negative opinion for Masivet

Adopted Reference Number: EMA/CVMP/198376/2011

Masivet-V-C-128-II-04 : EPAR - Refusal Assessment Report - Variation

CVMP post-authorisation summary of negative opinion for Masivet

Adopted Reference Number: EMA/CVMP/177595/2010

Initial marketing authorisation documents

Masivet : EPAR - Scientific Discussion

Masivet : EPAR - Procedural steps taken before authorisation

Committee for medicinal products for veterinary use summary of opinion: Masivet: International Non-proprietary Name (INN): Masitinib mesylate

Adopted Reference Number: EMEA/CVMP/488287/2008